CYSTO-CONRAY II
Details
- Status
- Prescription
- First Approved
- 1972-04-17
- Routes
- INTRAVESICAL
- Dosage Forms
- SOLUTION
CYSTO-CONRAY II Approval History
What CYSTO-CONRAY II Treats
1 indicationsCYSTO-CONRAY II is approved for 1 conditions since its original approval in 1972. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Cystourethrography
CYSTO-CONRAY II Boxed Warning
NOT FOR INTRAVASCULAR ADMINISTRATION NOT FOR INTRATHECAL USE...
NOT FOR INTRAVASCULAR ADMINISTRATION NOT FOR INTRATHECAL USE
Drugs Similar to CYSTO-CONRAY II
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CYSTO-CONRAY II FDA Label Details
ProIndications & Usage
Cysto-Conray II is indicated for use in retrograde cystography and cystourethrography.
NOT FOR INTRAVASCULAR ADMINISTRATION NOT FOR INTRATHECAL USE...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.